Molecular targets of gambogic acid in cancer: recent trends and advancements.
about
Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2).Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancer.Phytochemical based nanomedicines against cancer: current status and future prospects.Gambogic acid regulates the migration and invasion of colorectal cancer via microRNA-21-mediated activation of phosphatase and tensin homolog
P2860
Molecular targets of gambogic acid in cancer: recent trends and advancements.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Molecular targets of gambogic acid in cancer: recent trends and advancements.
@en
type
label
Molecular targets of gambogic acid in cancer: recent trends and advancements.
@en
prefLabel
Molecular targets of gambogic acid in cancer: recent trends and advancements.
@en
P2093
P2860
P1433
P1476
Molecular targets of gambogic acid in cancer: recent trends and advancements.
@en
P2093
Dharambir Kashyap
Gaurav Kumar
Rajkumar Mondal
P2860
P2888
P304
12915-12925
P356
10.1007/S13277-016-5194-8
P577
2016-07-22T00:00:00Z
P6179
1018486507